Effects of dissolved calcium and phosphorous on osteoblast responses.
The dissolution behavior of hydroxyapatite (HA) and its effect on the initial cellular response is of both fundamental and clinical importance. In this study, plasma-sprayed HA coatings were characterized by X-ray diffraction and Fourier transform infrared spectroscopy (FTIR). Calcium (Ca) and inorganic phosphorous (Pi) ions released from plasma-sprayed HA coatings within 3 weeks were measured by flame atomic absorption and colorimetrically molybdenum blue complex, respectively. To investigate the effect of dissolution of HA coatings on osteoblast response, additional Ca and Pi were added into the cell culture media to simulate the dissolution concentrations. Human embryonic palatal mesenchyme cells, an osteoblast precursor cell line, were used to evaluate the biological responses to enhanced Ca and Pi media over 2 weeks. Osteoblast differentiation and mineralization were measured by alkaline phosphatase-specific assay and 1,25 (OH)2 vitamin D3 stimulated osteocalcin production. The coatings exhibited an HA-type structure. FTIR indicated the possible presence of carbonates on the coatings. A dissolution study indicated a continual increase in Ca and Pi over time. In the cell culture study, enhanced osteoblast differentiation occurred in the presence of additional Ca concentration in the cell culture media. However, additional Pi concentration in the cell culture media was suggested to slow down osteoblast differentiation and mineralization.
Ma
S
S
School of Dentistry, University of Texas Health Science Center at San Antonio, USA.
Yang
Y
Y
Carnes
D L
DL
Kim
K
K
Park
S
S
Oh
S H
SH
Ong
J L
JL
D002118:Calcium / Q000032:analysis / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D020099:Coated Materials, Biocompatible / Q000737:chemistry*; D018360:Crystallography, X-Ray; D017886:Durapatite / Q000737:chemistry*; D006801:Humans; D007477:Ions; D059630:Mesenchymal Stem Cells / Q000187:drug effects / Q000378:metabolism; D010006:Osteoblasts / Q000187:drug effects* / Q000378:metabolism; D015675:Osteocalcin / Q000096:biosynthesis; D010758:Phosphorus / Q000032:analysis / Q000494:pharmacology*; D012996:Solutions; D013054:Spectrophotometry, Atomic; D017550:Spectroscopy, Fourier Transform Infrared
D020099:Coated Materials, Biocompatible; D007477:Ions; D012996:Solutions; D015675:Osteocalcin; D010758:Phosphorus; D017886:Durapatite; D002118:Calcium